<scp>FIGO</scp> staging of endometrial cancer: 2023
Jonathan S. Berek(Stanford Health Care), Nicole Concin(Medical University of Vienna), David K. Gaffney(University of Utah), Kristina Lindemann(Norwegian Cancer Society), Xavier Matías‐Guiu(Universitat de Lleida), Carien L. Creutzberg(Leiden University Medical Center), Christina Fotopoulou(Ovarian Cancer Action), David G. Mutch(Cancer Research Center), Sean Kehoe(University College Birmingham)
Cited by 926
Related Papers
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
|Journal of Clinical Oncology|2000|2.3k
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
|International Journal of Gynecological Cancer|2020|1.9k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k